TY - JOUR
T1 - Medium chain acyl-CoA dehydrogenase deficiency detected among Hispanics by New Jersey newborn screening
AU - Anderson, Sharon
AU - Botti, Christina
AU - Li, Bo
AU - Millonig, James H.
AU - Lyon, Elaine
AU - Millson, Alison
AU - Karabin, Suzanne S.M.
AU - Brooks, Susan Sklower
PY - 2012/9
Y1 - 2012/9
N2 - In the follow-up of New Jersey newborn screens suggestive of medium chain acyl-CoA dehydrogenase deficiency (MCADD) during a 30-month period, we identified five patients of Hispanic American ethnicity. With information provided by the New Jersey Department of Health and Human Services Newborn Screening program we calculated an overall cumulative incidence of approximately 7.20/100,000 for MCADD; 7.58/100,000 among Hispanic Americans and 7.08/100,000 among non-Hispanic Americans. Among the five Hispanic American infants who screened positive, a common variant (c.443G>A [p.R148K]) was identified which accounted for 30% of the alleles; c.799G>A (p.G267R) and c.985A>G (p.K329E) each accounted for an additional 20%; and a novel variant c.302G>A (p.G101E) was identified in one patient. Although treated prospectively during interim illnesses to prevent unwanted sequelae; till date, none of the patients carrying the c.443G>A variant have been symptomatic.
AB - In the follow-up of New Jersey newborn screens suggestive of medium chain acyl-CoA dehydrogenase deficiency (MCADD) during a 30-month period, we identified five patients of Hispanic American ethnicity. With information provided by the New Jersey Department of Health and Human Services Newborn Screening program we calculated an overall cumulative incidence of approximately 7.20/100,000 for MCADD; 7.58/100,000 among Hispanic Americans and 7.08/100,000 among non-Hispanic Americans. Among the five Hispanic American infants who screened positive, a common variant (c.443G>A [p.R148K]) was identified which accounted for 30% of the alleles; c.799G>A (p.G267R) and c.985A>G (p.K329E) each accounted for an additional 20%; and a novel variant c.302G>A (p.G101E) was identified in one patient. Although treated prospectively during interim illnesses to prevent unwanted sequelae; till date, none of the patients carrying the c.443G>A variant have been symptomatic.
KW - Medium chain acyl-CoA dehydrogenase deficiency (MCADD)
KW - Newborn screening
UR - http://www.scopus.com/inward/record.url?scp=84865563016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865563016&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/ajmg.a.35448
DO - https://doi.org/10.1002/ajmg.a.35448
M3 - Article
C2 - 22848008
SN - 0148-7299
VL - 158 A
SP - 2100
EP - 2105
JO - American Journal of Medical Genetics - Seminars in Medical Genetics
JF - American Journal of Medical Genetics - Seminars in Medical Genetics
IS - 9
ER -